In this thesis, we developed a label-free imaging method based on Second-Harmonic Generation microscopy in polarization (pSHG) to probe and quantify distinct conformations of myosin in relaxed muscle. Specifically, we investigated whether pSHG is sensitive enough to distinguish between the disordered-relaxed (DRX) and super-relaxed (SRX) states—two functionally distinct configurations that regulate myosin’s availability and energy consumption. This conformational balance is often disrupted in cardiac diseases such as human hypertrophic cardiomyopathy (HCM), contributing to mechanical and energetic dysfunction. We validated the sensitivity of pSHG using pharmacological agents—deoxyATP and Mavacamten—to shift the DRX/SRX equilibrium. We then applied this technique to a minipig model carrying the R403Q mutation, associated with HCM. Our results show that this mutation increases the population of myosin in the DRX state and enhances intrinsic ATPase activity. By combining pSHG structural data with energetic measurements, this work offers new insights into the molecular mechanisms underlying sarcomeric cardiomyopathies and highlights SHG microscopy as a valuable tool for probing myosin structural dynamics in intact muscle.
Probing relaxed myosin states in hypertrophic cardiomyopathy by second harmonic-generation microscopy / Giulia Arecchi; Leonardo Sacconi; Chiara Tesi. - (2025).
Probing relaxed myosin states in hypertrophic cardiomyopathy by second harmonic-generation microscopy
Giulia Arecchi
;Leonardo Sacconi;Chiara Tesi
2025
Abstract
In this thesis, we developed a label-free imaging method based on Second-Harmonic Generation microscopy in polarization (pSHG) to probe and quantify distinct conformations of myosin in relaxed muscle. Specifically, we investigated whether pSHG is sensitive enough to distinguish between the disordered-relaxed (DRX) and super-relaxed (SRX) states—two functionally distinct configurations that regulate myosin’s availability and energy consumption. This conformational balance is often disrupted in cardiac diseases such as human hypertrophic cardiomyopathy (HCM), contributing to mechanical and energetic dysfunction. We validated the sensitivity of pSHG using pharmacological agents—deoxyATP and Mavacamten—to shift the DRX/SRX equilibrium. We then applied this technique to a minipig model carrying the R403Q mutation, associated with HCM. Our results show that this mutation increases the population of myosin in the DRX state and enhances intrinsic ATPase activity. By combining pSHG structural data with energetic measurements, this work offers new insights into the molecular mechanisms underlying sarcomeric cardiomyopathies and highlights SHG microscopy as a valuable tool for probing myosin structural dynamics in intact muscle.| File | Dimensione | Formato | |
|---|---|---|---|
|
Arecchi_PhD Thesis_XXXVII Cycle.pdf
embargo fino al 21/04/2026
Tipologia:
Tesi di dottorato
Licenza:
Tutti i diritti riservati
Dimensione
3.09 MB
Formato
Adobe PDF
|
3.09 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



